Background. French military surveillance identified an increase in Plasmodium ovale attacks among soldiers in Ivory Coast. This emergence and the low sensitivity of biological tests raise the question of a possible role of P. ovale variant species.
Malaria is a threat to travelers in tropical endemic areas, especially to soldiers working under field conditions [1, 2] . Each year, 40 000 French soldiers stay in or travel through malaria-infected areas, using mandatory mosquito-fighting measures and chemoprophylaxis (chloroquine-proguanil up to 2002, doxycycline from 2003 to date). Bouts of Plasmodium falciparum are already well described because of their high incidence and severity, contrary to non-falciparum "bouts," especially bouts of Plasmodium ovale, which are less frequent and benign (5% of the cases) [1] . The permanent monitoring of malaria among French forces identified an unexpected peak of P. ovale attacks among soldiers during or after a stay in the Republic of Ivory Coast [3, 4] . As observed among French civilian travelers [5] , P. ovale malaria was a rare event for French forces before this outbreak, far less frequent than P. falciparum. This unexpected increase of P. ovale attacks was of concern for the French military medical authorities due to incapacitation of infected soldiers with attacks in the field; small outbreaks in several military units; diagnostic difficulties due to poor sensitivity of clinical and biological tools, including rapid diagnostic tests used in the field since 2002; and the need for a combined treatment with chloroquine to cure the attack and primaquine to avoid subsequent relapses [6] . Recently, Sutherland et al discovered the existence of 2 putative subspecies of P. ovale in West African countries [7, 8] , which made it possible to study the epidemiological evolution of P. ovale subspecies.
The epidemiological, clinical, biological, and molecular aspects of this significant outbreak are reported here and the reasons for this emergence are discussed.
PATIENTS AND METHODS
Epidemiological surveillance in the French armed forces is the continuous and systematic collection, analysis, interpretation, and feedback of epidemiological data about the main relevant infectious and noninfectious medical events by all military physicians. The study population consists of French military personnel, regardless of location (France, French and foreign overseas territories). The case definition for malaria is either onset of symptoms associated with the presence of plasmodium on thick and thin blood smears, positivity of Quantitative Buffy Coat (QBC) test and/or rapid diagnostic test (antigenic tests: BinaxNOW Malaria, Inverness Medical, then Core Malaria Pan/Pv/Pf, Fumouze Diagnostics since 2004). The species diagnosis is based on microscopic examination and/or antigenic tests and/or polymerase chain reaction (PCR). When necessary, blood samples were shipped from the field or hospitals to the Malaria Reference Centre in the Institute of Tropical Medicine of the Military Health Service (Le Pharo, Marseille) so that molecular diagnosis could be performed [9] .
Each case of malaria must be declared, using a questionnaire about location during stay, sociodemographic characteristics, behavior regarding mandatory mosquito-fighting measures and chemoprophylaxis, clinical and biological features, parasitological diagnosis, treatments, and outcome. The data of all P. ovale malaria attacks declared to the surveillance system between 1993 and 2012 were reviewed.
A sample of these attacks was more deeply analyzed by the study conducted on all soldiers with a P. ovale attack linked to a stay in the Republic of Ivory Coast who were managed between 2000 and 2009 in Laveran (Marseille) and Begin (SaintMandé) Military Teaching Hospitals, which are reference centers for tropical medicine and infectious diseases for the French Army. Epidemiological, clinical, and biological characteristics, treatment, and outcome were also collected. These soldiers were a subgroup of a series of patients with nonfalciparum malaria imported in French hospitals [10] .
For the available clinical materials, diagnosis (PCR) was completed by putative subspecies P. ovale genotyping [7] . DNA was extracted from blood samples by means of the QIAamp DNA Blood Mini Kit (Qiagen). Plasmodium ovale reticulocytebinding protein homologue (Porbp2: GU813972.1/GU813971.1), and P. ovale tryptophan-rich antigen genes (Potra: GU813975.1/ GU813973.1/GU813974.1) were amplified by PCR using the following primers [7] : 5′ ATGTTGGAAACAACTGACACC 3′ (forward) and 5′ GGGCGTAATAGTAAGGTAGCG (reverse) for Porbp2; 5′ TTAGACATTGAAAATGACCC 3′ (forward) and GTGTTTGTAGTATTTACAGG (reverse) for Potra. The reaction mixture consisted of approximately 10 ng of genomic DNA, 0.5 µM of forward and reverse primers, 1× buffer (50 mM potassium chloride, 10 mM Tris, pH 8.3), 2.5 mM magnesium chloride, 200 µM deoxynucleotide triphosphate, and 2.5 U Red Gold Star DNA polymerase (Eurogentec) in a final volume of 25µL. The thermal cycler (T3 Biometra) was programmed as follows: an initial 94°C for 2 minutes, followed by 40 cycles of 94°C for 30 seconds, 55°C for 30 seconds, and 72°C for 50 seconds for Porbp2 and 45 cycles of 94°C for 30 seconds, 55°C for 30 seconds, and 60°C for 30 seconds for Potra. A final 5-minute extension step was performed at 72°C for Porbp2 and 60°C for Potra. The PCR products were loaded on 2% agarose gel containing 0.5 μg/mL ethidium bromide. The amplified fragments were purified using the High Pure PCR Product Purification Kit (Roche). The purified fragments were sequenced using ABI Prism Big Dye Terminator cycle sequencing ready reaction kits (version 3.1; Applied Biosystems) using the above-described primers. The sequence reaction products were purified using the BigDye XTerminator purification kit (Applied Biosystems), in accordance with the manufacturer's instructions. The purified products were sequenced using an ABI Prism 3100 analyzer (Applied Biosystems). Sequences were analyzed using Bioedit software (version 7.0.9.0) [11] . As described by Sutherland et al [7] , amplification fragment length polymorphism and 20 point mutations were analyzed for Potra and Porbp2, respectively.
For the statistical analysis, all data were entered in an Excel database and the analysis was conducted with R software, using Fisher exact test, Student t test, or Mann-Whitney/ Wilcoxon tests.
RESULTS
The surveillance study ran from January 1993 to December 2012. (Table 1) . A total of 328 P. ovale attacks were declared, including 27 cases with P. ovale-P. falciparum coinfection. Considering the epidemiological and parasitic results, a misdiagnosis of Plasmodium vivax could not be excluded in 13 cases. Incidence peaked in 2005, or in 2009 if adjusted to the number of soldiers ( Figure 1 ). An annual peak of P. ovale attacks was observed in June. The proportion of P. ovale attacks among all malaria cases progressively increased with a peak in 2009, whereas the global malaria incidence decreased at the end of the study period. Almost all infected soldiers were men (n = 321 [98%]), mostly working in the army (97%). Median age was 27 years (range, 17-48). The majority of the patients (n = 304 [93%]) developed symptoms once they had returned to a nonendemic area. Disease onset was on average 219 days after return (median, 140; range, 1-2048) and 189 days after the end of chemoprophylaxis. A proven previous P. ovale attack linked to the same stay in the Republic of Ivory Coast was identified in 37 soldiers (14% with doxycycline, 7% with other drugs; P = .4); 4 of them had 3 relapses. The mean time between an attack and its subsequent relapse was 148 days (median, 99; range, 6-516).
It was possible to identify 42 clusters (same units and stay): 18 clusters of 2 cases, 11 of 3 cases, 6 of 4 cases, and 7 of up to 5 cases. The median time between the first and last case was 102 days (range, 1-620).
When mentioned, chemoprophylaxis was doxycycline (n = 295 [92%]), chloroquine-proguanil (n = 15 [5%]), and mefloquine (n = 10 [3%]). Compliance with chemoprophylaxis was available for 143 soldiers, and 54 (38%) declared correct compliance (53% during the stay vs 36% after the return; P = .5). Delay until onset of symptoms did not depend on type of chemoprophylaxis or compliance.
Results of diagnostic tests were available for 315 P. ovale attacks. The diagnosis was mainly established with a thick blood smear (97%) and sometimes with antigenic tests only (3%) when no other diagnostic tool was available in the field. A good concordance was found between positive thick blood smears and QBC tests (67/78 [86%]), whereas a very low concordance was found with antigenic tests (34/104 [33%]).
Most reported cases had classic features (96%). All attacks of P. ovale malaria were considered uncomplicated. However, admission to a medical unit or hospital ward was decided in 233 cases (71%). Median time of disability was 7 days.
The reported first treatment of P. ovale attacks was mostly quinine (52%) or chloroquine (35%). Quinine was preferentially used in case of biparasitism with P. falciparum or doubt concerning P. vivax infection (18% vs 4% for isolated P. ovale attack; P = 8.10 −6 ), and in the field (10% vs 1% for imported cases; P = 3.10 −4 ). The other treatments were mefloquine (7%), atovaquone plus proguanil (4%), and halofantrin (2%). The hospital-based study in 31 soldiers returning from the Republic of Ivory Coast allowed a detailed clinical and biological description of P. ovale attacks to be made. The reported clinical changes were fever (>37.7°C, 84%; >38.5°C, 61%), headache (39%), vomiting (19%), nausea (13%), abdominal pain (13%) including hepatalgia (3 cases) or splenalgia (1 case), splenomegaly (13%), cough (13%), diarrhea (10%), jaundice (6%), and hepatomegaly (3%). Main biological changes are shown in Table 2 . Mean parasitism was 0.17% (minimum = 0.01%, median = 0.1%, maximum = 0.7%).
Nineteen clinical isolates collected between 2004 and 2010 from soldiers returning from Ivory Coast with P. ovale infection were obtained for molecular investigations. According to singlenucleotide polymorphism and in/del polymorphism within the Porbp2 and Potra genes, respectively, 95% (18/19) of P. ovale isolates genotyped were classic (P. ovale curtisi) and 5% (1/19) were variant (P. ovale wallikeri). Sequences were consistent with classic and variant haplotypes (Table 3) . Among classic haplotypes, we noted additional single-nucleotide polymorphisms within Porbp2 at codons 123 (A/T), 124 (C/G), and 744 (T/ C). Moreover, classic haplotypes exhibited 2 alleles at the Potra locus, the expected 347 bp and a new size of 365 bp. The variant amplified fragment size 293 bp.
DISCUSSION
This study presents the results of one of the main series on P. ovale attacks, thanks to the close surveillance of the entire military population that makes it possible to collect rare events. It confirms the difficulties previously mentioned in diagnosing P. ovale attacks in travelers [5, 12] , and brings a good overview on this neglected tropical disease. Twenty percent of the patients had no fever, which is commonly the major sign pointing to malaria [13] . The other clinical signs were not specific: it was easy to think incorrectly of acute gastroenteritis in patients who had diarrhea, or of bronchitis where symptoms included a cough. Biological signs were often useless as already mentioned by Bottieau et al [14] ; 71% of the patients did not have anemia and 23% did not have thrombocytopenia.
Moreover, the majority of the bouts occurred outside Ivory Coast, a long time after the return to a nonendemic area and the end of chemoprophylaxis (in metropolitan France, French overseas territories, or other French Forces deployments such as Afghanistan). Indeed, the reduction of the length of stays since 2001 (from 2 years to 4 months) and the use of doxycycline could explain this phenomenon [15] . The median delay until the onset of symptoms after the return from Ivory Coast was 5 months, which is much longer than for P. falciparum, and reduces remembrance of the stay.
It is now recognized that parasitological diagnostic tools are poorly sensitive for P. ovale attacks, especially in cases with low parasitism [16] [17] [18] . Thus, diagnosis is commonly delayed or missed: When the hypothesis of imported P. ovale malaria is credible, microscopic searches with thick and thin blood smears should be repeated several times [19] . Sensitivity of the rapid diagnostic test was only 32% in our series, and its negativity cannot rule out the diagnosis [17, 18] . No rapid diagnostic test available today has capability to detect P. ovale-specific antigen and thus give a species-specific diagnosis. Molecular detection using PCR represents a real step forward in confirming the diagnosis, but is still not routinely available [20] .
Our genotyping of P. ovale highlights not only a new polymorphism but also the existence of 2 variants of P. ovale as already described in other West African countries by Sutherland et al [7, 8] , and more recently in Ivory Coast [21, 22] : P. ovale curtisi (18/19) and P. ovale wallikeri (1/19). The proportion of variant (5%) does not correspond to the lack of sensitivity (68%). That is why low sensitivity of biomolecular tests (PCR and rapid antigenic tests) is more likely explained by polymorphisms. It can affect gene regions coincident with the sequences of the primers used in the PCR protocols, or perhaps gene regions coincident with antigens used in diagnostic tests [21, 23] .
The treatment of P. ovale attacks in the reported series was rather uniform in relation with a specific formation on malaria treatment for all military physicians and with the antimalarial drugs available in France and on the field. Half of the patients were treated with quinine, with one-third for biparasitism or doubt with other species of Plasmodium and about one-fifth for vomiting. The other patients were treated in accordance with World Health Organization recommendations, which are based on chloroquine (25 mg/kg for 3 days) for the attack. Administration of primaquine (30 mg/day for 14 days) was always started in France in patients without G6PD deficiency according to the French recommendations [24] .
Despite these diagnostic difficulties, the progression of the incidence rate from 1993 to 2012 shows an epidemic peak of P. ovale attacks among the French armed forces (Figure 1) . The real number of P. ovale attacks was probably higher when considering the difficulties in diagnosis. Retrospectively, undiagnosed P. ovale attacks likely accounted for a significant part of the unexplained fevers identified by the French military physicians in Ivory Coast. Incidence rates of "unexplained fevers" have decreased from 86 per 1000 person-years through 2001 to 15 per 1000 person-years since 2002 (unpublished surveillance data, available on request) after the availability of the antigenic tests on the field since 2002. Nevertheless, despite this progress, P. ovale attacks were likely missed with these poorly sensitive tests, and many soldiers treated for P. ovale malaria diagnosed in French military hospitals declared short-lived and benign fevers occurring in the field [10] . We rule out the role of a putative spread of P. ovale wallikeri in this emergence because the epidemic peak occurred in 2005, whereas the only variant bouts we found occurred in 2010. During this time, the situation in the Republic of Ivory Coast changed. Whereas the French army was usually based in Port Bouët (Abidjan), doing training missions in the countryside, French troops were deployed throughout the whole country from the 2001 civil war until 2009 [25] . The main locations where troops were stationed were Abijdan, Bouake, and Yamoussoukro and the forest and savanna hinterland, where P. ovale incidence is greater [26] . Malaria transmission in Ivory Coast could also have changed, depending on environmental conditions and vector reproduction, as already demonstrated in other West African countries [27] [28] [29] . Application of the mosquito-fighting strategy and compliance with chemoprophylaxis did not play a role in this trend, as they did not change during this period [30, 31] . It is interesting to note that only 5% of the patients applied the whole strategy, which could argue in favor of its effectiveness. This increase occurred simultaneously with the change of chemoprophylaxis from chloroquine with proguanil to doxycycline starting in 2002. This drug switch seems to be the key point of this emergence of P. ovale. Doxycycline is effective on blood stages of malaria species, but not on P. ovale hepatic dormant forms [15] ; therefore, attacks occurred at the end of chemoprophylaxis when troops returned to a nonendemic area. In contrast, it appears that a large fall in total malaria case numbers occurred as the same time, suggesting that P. falciparum came under much better control.
This outbreak of P. ovale malaria was responsible for a heavy burden for French forces: morbidity and incapacitation of deployed soldiers on the field or after the return, healthcare costs for diagnosis and treatment, and loss of confidence by the troops in doxycycline chemoprophylaxis. A similar negative analysis was made recently in French Guyana for P. vivax outbreaks [32] . These 2 neglected relapsing species of malaria raise the similar problem of finding an ideal prevention for the forces deployed in areas endemic for both falciparum and non-falciparum malaria. To date, there is no well-tolerated chemoprophylaxis with a validated efficacy against P. falciparum, P. vivax, and P. ovale. T  G  C  T  A  A  C  A  T  A  T  A  T  A  A  T  A  T  T  A  AFLP IC01 * * * *
CONCLUSIONS
Plasmodium ovale malaria emergence among the French armed forces in the Republic of Ivory Coast may have had many causes, including increased exposure or low effectiveness of doxycycline for P. ovale malaria prevention. The spread of the use of rapid diagnostic tests has made diagnosis easier, especially in the field, but due to the lack of sensitivity, many P. ovale attacks still remained misdiagnosed. The existence of polymorphism rather than variant forms of P. ovale could explain this phenomenon. Improving diagnostic tools is key to proposing adequate treatment. The recent deployment of French armed forces in Mali will probably once again affect P. ovale incidence. This unexpected emergence of P. ovale malaria in the French armed forces in the Republic of Ivory Coast highlights some new challenges that the international forces recently deployed in subSaharan Africa could have to face.
